Oscillation and rapid changes of NF1 mRNA steady-state levels in cultured human keratinocytes

[1]  J. Koivunen,et al.  New function for NF1 tumor suppressor. , 2000, The Journal of investigative dermatology.

[2]  W. Krone,et al.  Tumor antigen HuR binds specifically to one of five protein-binding segments in the 3'-untranslated region of the neurofibromin messenger RNA. , 2000, Biochemical and biophysical research communications.

[3]  D. Kaufmann,et al.  Posttranslational regulation of neurofibromin content in melanocytes of neurofibromatosis type 1 patients , 1999, Archives of Dermatological Research.

[4]  J. Peltonen,et al.  Upregulation of tumor suppressor protein neurofibromin in normal human wound healing and in vitro evidence for platelet derived growth factor (PDGF) and transforming growth factor-beta1 (TGF-beta1) elicited increase in neurofibromin mRNA steady-state levels in dermal fibroblasts. , 1998, The Journal of investigative dermatology.

[5]  B. Korf,et al.  The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. , 1997, JAMA.

[6]  R. Eckert,et al.  The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. , 1997, Physiological reviews.

[7]  P. Kuehl,et al.  Post-transcriptional regulation of neurofibromin level in cultured human melanocytes in response to growth factors. , 1997, The Journal of investigative dermatology.

[8]  G. Skuse,et al.  Genetic and epigenetic mechanisms in the pathogenesis of neurofibromatosis type I. , 1995, Journal of neuropathology and experimental neurology.

[9]  W. Yeudall,et al.  Effects of transforming growth factor beta-1 on growth-regulatory genes in tumour-derived human oral keratinocytes. , 1995, British Journal of Cancer.

[10]  S. Peltonen,et al.  Neurofibromin: expression by normal human keratinocytes in vivo and in vitro and in epidermal malignancies. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[11]  F. Collins,et al.  Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis , 1993, Nature Genetics.

[12]  F. McCormick,et al.  NF is enough of GAP , 1992, Nature.

[13]  F. Collins,et al.  Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients , 1992, Nature.

[14]  D. Lowy,et al.  Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis , 1992, Cell.

[15]  M. Boguski,et al.  cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. , 1991, Genomics.

[16]  F. Collins,et al.  Identification of the neurofibromatosis type 1 gene product. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[17]  F. Tamanoi,et al.  The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae , 1990, Cell.

[18]  W. Lee,et al.  Structure of the human retinoblastoma gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[19]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[20]  V. M. Riccardi,et al.  Von Recklinghausen neurofibromatosis. , 1981, The New England journal of medicine.